Status | Study |
Completed |
Study Name: Julina Post-marketing Surveillance for Climacteric Symptoms in Japan Condition: Osteoporosis, Postmenopausal Date: 2011-06-16 Interventions: Drug: E2 transdermal (Julina, BAY86-5435) Patients in daily life treatment receiving Julina for postmeno |
Completed |
Study Name: Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis Condition: Postmenopausal Osteoporosis Date: 2011-05-04 Interventions: Drug: disodium clodronate 200 mg/4 ml with 1% lidocaine |
Completed |
Study Name: Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment Condition: Osteoporosis, Postmenopausal Date: 2010-06-03 Interventions: Other: OPSAT-Q A linguistically validated Korean version of OPSAT-Q |
Completed |
Study Name: BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis Condition: Postmenopausal Osteoporosis Date: 2007-10-16 Interventions: Drug: ibandronate [Bonviva/Boniva] |
Completed |
Study Name: A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) Condition: Postmenopausal Osteoporosis Date: 2007-10-16 Interventions: Drug: Ibandronate Participants will receive ibandronate 150 mg QM orally for 6 months. |
Completed |
Study Name: ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. Condition: Post Menopausal Osteoporosis Date: 2007-10-16 Interventions: Drug: ibandronate [Bonviva/Boniva] 150mg po monthly for 6 months |
Completed |
Study Name: SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. Condition: Post Menopausal Osteoporosis Date: 2007-10-16 Interventions: Drug: ibandronate [Bonviva/Boniva] |
Completed |
Study Name: Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis Condition: Osteoporosis, Post-Menopausal Date: 2007-09-18 Interventions: Drug: Teriparatide Teriparatide 20 micrograms/daily subcutaneously |
No longer available |
Study Name: A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. Condition: Postmenopausal Osteoporosis Date: 2007-06-27 Interventions: Drug: ibandronate [Bonviva/Boniva] 3mg iv every 3 months |
Completed |
Study Name: Risedronate Sodium in Post Menopausal Osteoporosis Condition: Osteoporosis, Postmenopausal Date: 2007-03-28 Interventions: Drug: risedronate sodium |